129S9/SvEv-Camk2aem1H/H

Status

Available to order

EMMA IDEM:16096
Citation informationRRID:IMSR_EM:16096 

Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information.

International strain name129S9/SvEv-Camk2aem1H/H
Alternative name129S9/SvEv-Camk2a/H
Strain typeEndonuclease-mediated
Allele/Transgene symbolCamk2aem1H
Gene/Transgene symbolCamk2a

Information from provider

Provider Mary Lyon Centre at MRC Harwell
Provider affiliationMary Lyon Centre at MRC Harwell
Genetic informationCamk2a, a subunit of holoenzyme Camk2, Is expressed primarily in glutamatergic neurons of the forebrain. Autophosphorylation of T286 in Cmk2a has previously been associated with spatial memory formation as well as induction of NMDA receptor dependant long term potentiation. This strain carries a a CRISPR/Cas9 induced mutation creating a series of point mutations; T286P in exon ENSMUSE00000572373 of CAMK2A and can be useful in studying the role of Camk2a as well as T286 phosphorylation in synaptic plasticity and neuronal circuit formation.
Phenotypic informationHomozygous:
No phenotype data available. Seizure like behavious observed on B6J background and the strain was threrefore crossed and maintained on 129. However, further welfare checks may be required.

Heterozygous:
No phenotype data available.
Breeding historyOriginated on C57BL/6J. Currently maintained on 129S9/SvEv
ReferencesNone available
Homozygous fertilenot known
Homozygous viablenot known
Homozygous matings requiredno
Immunocompromisedno

Information from EMMA

Archiving centreMary Lyon Centre at MRC Harwell, Oxford, United Kingdom

Disease and phenotype information

Orphanet associated rare diseases, based on orthologous gene matching


Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable), as well as a CRISPR surcharge.

More details on pricing and delivery times

Practical information

Genotyping protocol

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
MTA will be issued after an order has been submitted.

EMMA conditions
Legally binding conditions for the transfer

Right strain for your research?

The information provided on this page is, to the best of EMMA’s knowledge, based on data supplied by the original provider. End users are responsible for reviewing these details and for validating the strain and its suitability for their experimental use.​
Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).